HER2 status is determined using fluorescence in situ hybridization (FISH) to evaluate HER2 gene expression or immunohistochemistry (IHC) to assess HER2 protein expression in primary breast cancer tissues [27,28]. This evidence concerns the gene ERBB2 and breast carcinoma.